The Potential of Stem Cell Therapy for Osteoarthritis and Rheumatoid Arthritis

被引:23
作者
Keerthi, Naveen [1 ]
Chimutengwende-Gordon, Mukai [1 ]
Sanghani, Anita [1 ]
Khan, Wasim [1 ]
机构
[1] Univ Coll London, Inst Orthopaed & Musculoskeletal Sci, Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England
关键词
Cartilage; inflammation; osteoarthritis; rheumatoid arthritis; stem cells; synovium; ARTICULAR-CARTILAGE DEFECTS; COLLAGEN-INDUCED ARTHRITIS; MESENCHYMAL STROMAL CELLS; BONE-MARROW; CHONDROGENIC DIFFERENTIATION; INTRAARTICULAR INJECTION; AUTOIMMUNE-DISEASES; ENHANCED REPAIR; EUROPEAN GROUP; TRANSPLANTATION;
D O I
10.2174/1574888X1130800062
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
Joint diseases are a major cause of disability and are a significant financial burden on health care systems. Regenerative medicine offers exciting possibilities for treating osteoarthritis and rheumatoid arthritis. As well as possessing the ability to differentiate into other tissue lineages, some stem cells such as mesenchymal stem cells possess immmunomodulatory properties that make them useful in the search for alternative treatments for rheumatoid arthritis specifically. Various studies have been carried out using animal models to evaluate the role of stem cells in the treatment of arthritis, with some research being translated into clinical studies. However, the number of patients used in some studies has left questions on the ability of stem cell therapy to treat arthritic conditions unanswered. This article reviews the innovative studies that have been carried out to treat arthritis using stem cells and also highlights the key challenges associated with these techniques.
引用
收藏
页码:444 / 450
页数:7
相关论文
共 92 条
[1]
ABC OF RHEUMATOLOGY - RHEUMATOID-ARTHRITIS .1. CLINICAL-FEATURES AND DIAGNOSIS [J].
AKIL, M ;
AMOS, RS .
BRITISH MEDICAL JOURNAL, 1995, 310 (6979) :587-590
[2]
Indoleamine 2,3-dioxygenase expression in trans-planted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes [J].
Alexander, AM ;
Crawford, M ;
Bertera, S ;
Rudert, WA ;
Takikawa, O ;
Robbins, PD ;
Trucco, M .
DIABETES, 2002, 51 (02) :356-365
[3]
Chondrogenic differentiation of human bone marrow mesenchymal stem cells in chitosan-based scaffolds using a flow-perfusion bioreactor [J].
Alves da Silva, M. L. ;
Martins, A. ;
Costa-Pinto, A. R. ;
Correlo, V. M. ;
Sol, P. ;
Bhattacharya, M. ;
Faria, S. ;
Reis, R. L. ;
Neves, N. M. .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2011, 5 (09) :722-732
[4]
[Anonymous], CAR MAN OST AD
[5]
Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis [J].
Augello, Andrea ;
Tasso, Roberta ;
Negrini, Simone Maria ;
Cancedda, Ranieri ;
Pennesi, Giuseppina .
ARTHRITIS AND RHEUMATISM, 2007, 56 (04) :1175-1186
[6]
Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components [J].
Barry, F ;
Boynton, RE ;
Liu, BS ;
Murphy, JM .
EXPERIMENTAL CELL RESEARCH, 2001, 268 (02) :189-200
[7]
Hydrogels that mimic developmentally relevant matrix and N-cadherin interactions enhance MSC chondrogenesis [J].
Bian, Liming ;
Guvendiren, Murat ;
Mauck, Robert L. ;
Burdick, Jason A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (25) :10117-10122
[8]
Black LL, 2007, VET THER, V8, P272
[9]
Black Linda L, 2008, Vet Ther, V9, P192
[10]
Cardiovascular biomaterials: when the inflammatory response helps to efficiently restore tissue functionality? [J].
Boccafoschi, F. ;
Mosca, C. ;
Cannas, M. .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2014, 8 (04) :253-267